IBB Holdings Information

IBB is an equity ETF with a total of 257 individual holdings. The top holdings are Gilead Sciences stock at 7.20%, Amgen at 6.68%, Vertex Pharmaceuticals at 6.22%, Regeneron Pharmaceuticals at 6.21%, and Alnylam Pharmaceuticals at 6.19%.

Total Holdings

257

Top 10 Percentage

47.32%

Asset Class

Equity

ETF Category

Health

Assets

5.68B

PE Ratio

19.21

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	GILD	Gilead Sciences, Inc.	7.20%	3,593,812
2	AMGN	Amgen Inc.	6.68%	1,372,776
3	VRTX	Vertex Pharmaceuticals Incorporated	6.22%	894,935
4	REGN	Regeneron Pharmaceuticals, Inc.	6.21%	629,281
5	ALNY	Alnylam Pharmaceuticals, Inc.	6.19%	753,903
6	IQV	IQVIA Holdings Inc.	3.42%	1,037,075
7	INSM	Insmed Incorporated	3.21%	1,250,004
8	ARGX	argenx SE	3.10%	232,774
9	MTD	Mettler-Toledo International Inc.	2.78%	125,120
10	NTRA	Natera, Inc.	2.32%	781,795
11	BIIB	Biogen Inc.	2.26%	884,534
12	ONC	BeOne Medicines AG	1.93%	337,342
13	UTHR	United Therapeutics Corporation	1.90%	265,986
14	WAT	Waters Corporation	1.87%	359,095
15	INCY	Incyte Corporation	1.69%	1,153,433
16	ILMN	Illumina, Inc.	1.56%	929,484
17	BNTX	BioNTech SE	1.54%	905,521
18	NBIX	Neurocrine Biosciences, Inc.	1.44%	577,295
19	MEDP	Medpace Holdings, Inc.	1.22%	141,006
20	GMAB	Genmab A/S	1.20%	2,453,041
21	EXEL	Exelixis, Inc.	1.10%	1,596,134
22	BMRN	BioMarin Pharmaceutical Inc.	1.09%	1,143,243
23	IONS	Ionis Pharmaceuticals, Inc.	1.04%	938,953
24	HALO	Halozyme Therapeutics, Inc.	1.00%	736,905
25	MDGL	Madrigal Pharmaceuticals, Inc.	0.92%	121,442

Showing 25 of 257 holdings

Subscribe to see the full list

Upgrade Now

As of Sep 12, 2025